No insider purchase over the last 90 days. The latest, by 노광, was filed 09 Jun 2026.
SunBio,Inc.: what insiders have been doing
SunBio,Inc. is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 1 November 2025 to 1 November 2026, the disclosure feed for SunBio,Inc. logged 7 filings by 1 insider.
Not one open-market sale was filed. On the buying side, 1 insider reported 7 purchases totalling €105k. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 노광 filed the largest purchase, €41k, on 11 March 2026, which represents 0.092% of the company's market value. The buyers include 1 chief executive.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 7 filings, this issuer sits right on that mark. Since 2021, the database holds 14 purchases and no sales by insiders of the company.
The latest purchase dates back some time: it was published 154 days ago, on 9 June 2026. The median gap between a trade and its publication by DART (FSS) is 1 day. Until a filing is published, the market cannot know about the trade.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -21.1%Entry ₩6,650 · Close 30 Oct 2026 ₩5,250
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 600 sharesShareKRXDART:20260609000216Canonical exit: 7 Sept 2026 (T+90)
- 4,200 shares@ ₩5,949.000.031% mcap19.5% of flowShareKRXDART:20260602000344Canonical exit: 31 Aug 2026 (T+90)
- 4,560 shares@ ₩7,137.000.042% mcap58.0% of flowShareKRXDART:20260423000113Canonical exit: 21 Jul 2026 (T+90)
- 5,300 shares@ ₩5,537.000.037% mcap23.3% of flowShareKRXDART:20260327000498Canonical exit: 24 Jun 2026 (T+90)
- 4,570 shares@ ₩5,104.50770.030% mcap42.0% of flowShareKRXDART:20260316000387Canonical exit: 9 Jun 2026 (T+90)
- 13,500 shares@ ₩5,295.77780.092% mcap57.2% of flowShareKRXDART:20260311003620Canonical exit: 7 Jun 2026 (T+90)
- 2,480 sharesShareKRXDART:20251105000092Canonical exit: 3 Feb 2026 (T+90)
- 4,600 sharesShareKRXDART:20251001000325Canonical exit: 30 Dec 2025 (T+90)
- 1,270,468 sharesKRXDART:20221116000099Canonical exit: 14 Feb 2023 (T+90)
- ShareKRXDART:20221017000165Canonical exit: 15 Jan 2023 (T+90)
- 186,453 sharesKRXDART:20220928000377Canonical exit: 27 Dec 2022 (T+90)
- 186,453 sharesKRXDART:20220928000491Canonical exit: 27 Dec 2022 (T+90)
- ShareKRXDART:20210415000181Canonical exit: 14 Jul 2021 (T+90)
- ShareKRXDART:20210222001494Canonical exit: 23 May 2021 (T+90)
14 of 14 declarations
About SunBio,Inc.
Sunbio operates in the health and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions in the healthcare field.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
